Find a Clinical Trial

HER2 Negative Breast Cancer

HCRN-BRE20-468 - A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study)

18+

Learn more

Protect IV

Impella® Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial

18-90

Learn more

Apple Watch Heart Failure Study

Monitoring Heart Failure Patients using Heart Rate Variability measured by the Apple Watch

22+

Learn more

MADIT S-ICD

Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator

65+

Learn more

OCS Heart Perfusion Registry

OCS Heart Perfusion Post- Approval Registry

18+

Learn more

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

18+

Learn more

Schiller Grant BC

Phenotyping Heart Failure Readmission Risk using Wearable Sensors and Machine Learning

21+

Learn more

PIVATAL

Prophylactic Intra-Operative Ventricular Arrhythmia Ablation in High-Risk LVAD Candidates

18+

Learn more

EVAHEART COMPETENCE

Prospective Multi-Center Randomized Study for Evaluating the EVAHEART2 Left Ventricular Assist System: the COMPETENCE Trial

18+

Learn more

Pulmonary vascular impedance in cardiogenic shock

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

18+

Learn more